The Global Medtech Hub - How Ireland is innovating for future healthcare and economic growth
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
The Global Medtech Hub How Ireland is innovating for future healthcare and economic growth Irish Medtech Association Statement of Strategy 2016-2020
We are reaching out to those who wish to be involved in the creation of a dynamic and exciting future for the medtech industry in Ireland. Contents 01 Foreword 02 Industry outlook 04 Industry profile 06 Drivers and opportunities for development 08 Mapping the medtech sector in Ireland 10 Our vision for the sector 10 Our mission 11 Strategy themes and actions 18 Key performance indicators 22 Mapping our world-class medtech sector 24 About Ibec 25 About the Irish Medtech Association 26 Our Board of Directors
Foreword
For over a decade the Irish Medtech Association, formerly
known as the Irish Medical Devices Association, the Ibec
group, has worked closely with industry and stakeholders
to make Ireland the best place for medtech business.
In order to achieve this, every four years a strategy is
developed to identify new opportunities, and reflect on
the progress we have made. But more importantly it’s a
chance to set-out our ambition for the future.
O
ur recent strategy has served us well. Along with best quality market insight and support from
It supported the leadership and dynamism a wide variety of sources, we have carved out the next
across this strong export-led sector which has phase towards an exciting future for Irish Medtech and our
seen growth in R&D investment across many members. We have a new vision and mission. A roadmap
Foreign Direct Investment and indigenous companies. The of where we need to be and how we can best get there.
sector has grown considerably over the past four years, with We are also keenly aware that one size does not fit all, and
29,000 people employed across 450 companies. Ireland’s we are confident that our approach caters for the many
medtech sector is the highest employer in Europe, per and varied requirements of our members now and into
capita, directly exporting to over 100 countries worldwide. the future. With four out of five medtech companies being
You should all be very proud of the role that your business SMEs or start-ups, we know that different companies have
and this industry are playing to make Ireland the fastest different needs. We promote the interests of the sector by
growing economy in Europe. collaborating on shared goals, co-ordinating on activities
and ensuring that each member is well represented to
But we still face challenges, now is the time to rethink our achieve their potential.
healthcare system and steer it back onto a sustainable path.
The medtech sector recognises that the current business We are reaching out to those who wish to be involved in the
model is coming to an end. As an industry, innovation creation of a dynamic and exciting future for the medtech
has always been at the heart of what we do. Innovation industry in Ireland. And through the provision of high-quality
will be key for developing better patient outcomes and a services to our member organisations, Irish Medtech stands
sustainable healthcare system. The sector has a lot to offer ready to help you as you navigate your way forward to make
to drive this important change. Ireland a global medtech hub.
The global medtech industry is expected to reach €475 To everyone who helped to get us to this point, thank you.
billion in 2018, an annual growth of 5.5%. Ireland should
maximise opportunities with growing demands to become
major contributors to global healthcare and the global James Winters
economy. Our continued success will depend more than Chair, Irish Medtech Association
ever on our ability to adapt and meet the challenges ahead. Vice President Manufacturing,
Global Joint Reconstruction Ireland,
We have been preparing for the next phase of our strategic DePuy Orthopaedics Worldwide
plan since mid-2012, when we conducted a mid-term
review to collect as much input as possible from our Conor Russell
members and stakeholders across the ecosystem. Vice Chair, Irish Medtech Association
VP, Operations, Boston Scientific
How Ireland is innovating for future healthcare and economic growth 01
Industry outlook
Ireland’s medical technology
industry has continued to
grow over the past four years.
At the same time the demand
for and cost of healthcare is
rising, which is challenging
most health economies across
the world. There is no doubt
adoption of technology will help
meet these challenges; however,
new business models will be
needed to drive new ideas.
T
he availability of improved outcome data from The recovery means there will be new manufacturing
healthcare solutions will likely drive increased data opportunities. Output in traditional manufacturing was
demands to support pricing and reimbursement. up 6.3% in 2014. However, much more can be done
As such, the Irish Medtech Association’s new to help the sector which still faces pressure from lower
mission statement reflects the need to build awareness cost economies. This can be managed by staying at
of the value of medtech. New economic models will be the forefront of advanced manufacturing and service
required that can evaluate the impact of new technology on excellence, investment in advanced and additive
the longer term outcome and total cost of a patient’s illness manufacturing technologies must be part of the plan
will need to be considered, as opposed to models that are ahead if we are to succeed.
based on cost alone. The medtech industry has a key role to
play in addressing the challenges that the global healthcare
systems face.
02 Irish Medtech Association Statement of Strategy 2016-2020
We must
embrace the skills
revolution, by adopting
strategies to ensure
continuous upskilling and
development of Ireland’s
workforce so that they
have the skills needed
today for the medtech
businesses of
tomorrow.
Foreign Direct Investment and indigenous companies are The global ethical compliance and regulatory landscape is
continuing to ‘move up the value chain’ and expand their also changing rapidly and Irish Medtech will continue to work
mandate which will lead to new research and product with stakeholders to provide best industry foresight. It’s vital
development programmes. Realising the full potential of the that the industry plays its role in ensuring the right conditions
cluster, we will deliver more research, development, design for growth are in place to support better patient outcomes.
and marketing of innovative technologies. New devices
developed from a range of converging technologies, in We are experiencing the age of the empowered patient, an
particular those which are focused on information technology age when users and patients will no longer be dictated to as
in connected health and big data are now an established they were in previous generations. In order to respond to this
growing market. The medtech sector is known for its ability shift, medtech businesses need a new set of ingredients to
to innovate. Ireland’s strength in IT means we are uniquely design their strategies to truly resonate in the marketplace.
placed to develop new products through collaboration. Given the industry’s existing capacity to adapt, it is well
Connected health will define a new approach to promote placed to address these challenges.
patient health, as well as drive economic success.
But to unleash our true potential and seize emerging
Nurturing entrepreneurship is bearing fruit with more opportunities, recognising and rewarding a culture of
investment in medtech start-ups. It is essential that innovation will play a vital role in stimulating the sector
entrepreneurial and intrapreneurial activity is well funded to develop new capabilities and meet the challenge of
to ensure successful new device companies emerge from achieving cost-effective, sustainable healthcare systems.
Ireland. A high level of mergers and acquisitions (M&A) Innovation and innovative thinking have transformed the
activity has and will continue to restructure the industry landscape for business in Ireland in the past, and will ensure
globally. There is an opportunity for Irish subsidiaries and that the medtech sector continues to thrive into the future.
indigenous companies to identify M&A targets through
business development activity in Ireland and Europe. This
could drive further entrepreneurial activity within the country Dr Sinead Keogh
and help further build Ireland’s reputation for medtech. Director, Irish Medtech Association,
a business association in Ibec
Growing exports will not be without its challenges as trade
barriers and local regulations may continue to impact export
potentials, but the Transatlantic Trade and Investment
Partnership (TTIP) offers growth opportunities for the sector.
How Ireland is innovating for future healthcare and economic growth 03
Industry profile
Ireland’s medtech sector is now
recognised as one of the top five
emerging global hubs.
n Ireland has a very strong sub-supply base with Major FDI and
many companies becoming globally preferred indigenous
vendors of choice for leading FDI enterprises. companies have
expanded their R&D
n The State will partner with leading international
mandate in recent
VC’s (Innovation Fund Ireland) to support the
years and have
growth of high technology companies. The
Seed and Venture Capital Scheme of €175
established
million is aimed at leveraging private funds to
create €700 million for investment over the
global R&D
next three years. centres of
n Collaboration between indigenous and FDI
excellence
enterprises and leading academic and key in Ireland
clinical opinion leaders is growing. This
collaboration is now a key competitive
strength internationally.
The challenge is to continue to develop
18
and integrate the broad range of strategic
competencies and support systems that will
enable this island to compete as a mature,
high value-added economy, with innovation
at its core.
of the world’s
top 25 medtech
companies
have a base
in Ireland
04 Irish Medtech Association Statement of Strategy 2016-2020
Ireland continues to be a leading
manufacturing hub for medtech, with:
Ireland’s medtech
sector employs
n 25% of the world’s
population that have
diabetes relying on
injectable devices
29,000
manufactured in
people across
Ireland – that is 450 companies.
over 30m people; More than 2,000 jobs have
been announced in the sector
n 33% of the world’s in Ireland since 2014
contact lenses being
manufactured in Ireland;
n 80% of global stent
production being carried
out in Ireland;
n 75% of global
orthopaedic knee
production
coming out
of Ireland.
60%
of the medtech
industry is indigenous,
and a significant
proportion are SMEs
The Irish medtech sector has been
recognised by the Government as a
Ireland is now one of the largest prime contributor to the growth of the
exporters of medical products in Irish economy, representing nearly
Europe, with annual exports of
€12.6 billion 10% of all
to over 100 countries worldwide exports
How Ireland is innovating for future healthcare and economic growth 05
Drivers and
opportunities for
development
Current drivers of the Irish medtech sector include:
World-class
technical and
Adaptable, managerial Competitive corporation
dynamic and talent tax rate and knowledge
“can do” attitude development box to
of workforce incentivise innovation
Aptitude and
Supportive
enthusiasm
environment
for innovation
for R&D
Favourable
Entrepreneurial regulatory
spirit environment
Efficient
collaboration
across diverse A culture
disciplines A history of of quality
manufacturing and ethical
excellence compliance
Product
development
expertise
06 Irish Medtech Association Statement of Strategy 2016-2020
Opportunities for development include:
Industry foresight
n Enhancing our capacity to address the globalisation of the industry and international competition.
n Expanding the mandate of FDI and indigenous companies in response to global trends.
n Adapting to the reduction in global healthcare expenditure.
n Building capability in advanced and additive manufacturing.
n Becoming a centre of excellence in innovation, underpinned by excellence in design.
n Increasing investment in process and product R&D in Ireland.
n Enhancing our capacity to address imminent changes to the regulatory and compliance environment
across the EU and beyond.
n Responding to changes in market dynamics such as the empowered patient and the patient as a consumer.
Ecosystem development
n Enhancing the Irish clinical research infrastructure by promoting a culture of innovation leadership
within the Irish healthcare system.
n Introducing new economic models to support sustainable development of the healthcare system
and encouraging faster adoption of new medtech.
n Developing a culture of commercialisation in Irish universities.
n Embedding entrepreneurial thinking across the curriculum from primary level to higher level education.
n Supporting the development of new education models for the sector such as apprenticeships.
n Building skills in health economics, as well as sales and marketing, to respond to changing market dynamics.
n Growing supports for upskilling within industry.
Future care continuum
n Leveraging Ireland’s recognised excellence in IT to support new connected health solutions.
n Enhancing high-level design, engineering, scientific skills and skills required for future technology convergence.
Entrepreneurship
n Growing the number of successful start-ups by improving policies and conditions to support start-ups
and supporting greater access to funding.
Membership experience
n Enhancing Irish Medtech’s reputation as Ireland’s foremost business representation group for the
medtech industry in the minds of members and key stakeholders.
n Delivering real value to members.
How Ireland is innovating for future healthcare and economic growth 07
Mapping the
medtech sector
in Ireland
Defining a medical technology company
Medical technology companies are defined as companies that:
n Design and/or manufacture medtech products and/or solutions.
n Manage significant international shared services from Ireland.
n Directly service the medtech sector.
The sector is diverse and the following eight broad headings have been established to describe
and categorise the sector in Ireland:
Diagnostic
Health software Ophthalmic
Service Vascular
Contract
manufacturing Orthopaedic
and/or design
Hospital and/or
homecare products
A map of the Sector by category is available on pages 22-23.
08 Irish Medtech Association Statement of Strategy 2016-2020A continuous
focus on innovation
is key for the
industry to thrive.
,eciveD noitasiralucsaveR parTobmE
.detimiL ivarueN
How Ireland is innovating for future healthcare and economic growth 09Our vision
for the sector
Ireland will be a global leader in innovative patient-centred
medical technology developments, products and solutions.
n Ireland will be a globally significant medical technology hub and the location of choice for the industry
due to our expertise and pro-business environment.
n Irish medical technology developments, products and solutions will be major contributors to global healthcare
and the global economy.
Our mission
Irish Medtech’s mission is to shape and deliver the
industry vision by:
n Driving significant agenda items towards the industry vision.
n Building awareness of the value of Irish medical technology for patients and the economy in Ireland and globally.
n Providing services, support and information which will add value to the businesses of our members.
n Facilitating interaction with other relevant sectors such as ICT, pharmaceutical, biotechnology, and materials to
encourage new healthcare solutions from technology convergence.
10 Irish Medtech Association Statement of Strategy 2016-2020Strategy themes and actions How Ireland is innovating for future healthcare and economic growth 11
01 INDUSTRY FORESIGHT
Driving our future
Strategic objective
Influence the strategic development of Irish Medtech
member organisations by delivering best-quality
industry foresight
n Scan areas of the ecosystem for new developments affecting members. Identify key areas for specific focus –
(e.g. Revision of the Medical Device and Diagnostics Directives, reimbursement policies, healthcare payers
and providers structure, tax regime, trade barriers).
n Establish appropriate forums to enable industry thought leaders in Ireland to share knowledge, discuss the impact
of changing models and where relevant, prepare for the future.
n Identify critical competencies and skills needed to align with new business models.
n If and when appropriate, take steps to advocate for and influence a new business environment.
» There is an opportunity for Ireland to respond to growing
global healthcare demands and grow exports.
12 Irish Medtech Association Statement of Strategy 2016-2020Achieving the full
ECOSYSTEM DEVELOPMENT
02
potential of the cluster
Strategic objective
To encourage and create an ecosystem that
sustains the evolution of the industry
n Build awareness of the value of medtech to facilitate positive policy decisions.
n Develop the existing manufacturing base, target supports for efficiency improvements and investments in
advanced, additive and cell manufacturing as well as the other key enabling technologies.
n Assist companies to expand and reach their full potential from concept to market.
n Target training and development of a talent pool to support strategy.
n Enhance the clinical research infrastructure and support the direction of academic research.
n Make Ireland an attractive employment destination.
n Promote policies to coordinate key resources to make Ireland a centre of excellence for the
development of healthcare technologies.
n Promote integrated and collaborative relationships across medtech stakeholders in the national,
and as appropriate, the global ecosystem.
» To achieve the potential of the cluster we will continue
to bring together indigenous and FDI enterprises for
collaboration between academic centres and key
opinion leaders. This will deliver further research,
development, design and marketing of innovative
medical technologies.
How Ireland is innovating for future healthcare and economic growth 1303 FUTURE CARE CONTINUUM
Maximising technology
innovation across
sectors to improve
patient outcomes
Strategic objective
Provide opportunities to maximise the generation of
innovative convergent technologies
n Facilitate interaction between industry sectors such as pharmaceuticals, biotechnology, ICT and materials to
encourage technology convergence in the development of new medical products and solutions.
n Leverage Ireland’s recognised excellence in the areas of data processing and cybersecurity to develop an ecosystem
which will successfully support the convergence of medtech with ICT to establish Ireland as a global destination for
connected healthcare solutions.
» New digitally enabled health applications have the
potential to transform healthcare which will be
aligned with new care models. Data will drive better
clinical decision making, improve outcome based
accountability and promote patient empowerment.
14 Irish Medtech Association Statement of Strategy 2016-2020Nurturing
04
ENTREPRENEURSHIP
entrepreneurship
Strategic objective
Develop policies and conditions where
entrepreneurship can thrive
n Encourage policies and conditions that would facilitate greater funding opportunities for indigenous
start-ups and growth companies.
n Promote policies and conditions that support government procuring medtech products from Irish start-ups.
n Expand and further develop the mentoring programme, set-up in conjunction with Enterprise Ireland where
experienced Irish Medtech members provide mentoring to entrepreneurs.
n Benchmark against “best in class” entrepreneurial countries and foster new ideas where appropriate.
» Nurturing entrepreneurship is bearing fruit with more
investment in medtech start-ups. A continuous focus
on innovation is key for the industry to thrive.
How Ireland is innovating for future healthcare and economic growth 1505 MEMBER EXPERIENCE
Delivering real
value to members
Strategic objective
Provide high-quality professional services to
member organisations that will impact positively
on their business performance
n Be the voice of the medtech industry in Ireland.
n Build awareness of the value of Irish medtech for patients and the economy in Ireland and globally.
n Actively connect peers to develop business links, address business concerns, exchange views and promote best practice.
n Engage with members to discuss their needs and aspirations and provide industry-specific, high-quality,
cost-effective training.
n Provide members with access to expertise, knowledge and insight across a broad suite of business-specific topics.
n Reinforce industry integrity and high ethical standards through the implementation and adoption of the Irish Medtech
Code of Ethical Business Practice.
n Continue to support and promote a culture of business excellence.
» Irish Medtech drives the industry vision by building
awareness of the value of medtech, our dedicated
team provides member services, networking and
industry insights. As part of Ibec we are working to
ensure that Ireland has the right policy environment
and conditions to drive economic success.
16 Irish Medtech Association Statement of Strategy 2016-2020The Irish Medtech
Board, working groups,
taskforces and executive
team will continue to
work closely with our
partners to deliver the
objectives of our
strategic vision
effectively.
How Ireland is innovating for future healthcare and economic growth 17Key
Performance
Indicators
18 Irish Medtech Association Statement of Strategy 2016-2020While not exhaustive, board performance indicators
have been identified for each of the strategic themes
that Irish Medtech has adopted.
INDUSTRY FORESIGHT
Driving our future
Influence the strategic development of Irish Medtech member organisations by delivering best-quality industry foresight.
n Annual Board review and validation of strategy.
n Increased employment in value add roles within the sector.
n Increased annual exports.
n Significant increase in the global share of niche markets.
ECOSYSTEM DEVELOPMENT
Achieving the full potential of the cluster
To encourage and create an ecosystem that sustains the evolution of the industry.
n Higher proportion of firms engaged in technological innovation.
n Increased R&D activity.
n Number of medtech companies gaining commercialisation funding.
n Number of convergent technology products developed and commercialised.
n Increased awareness of the value of medtech amongst stakeholders.
n Increased university commercialisation output.
n Greater involvement of clinicians in medtech innovation.
FUTURE CARE CONTINUUM
Maximising technology innovation across sectors
to improve patient outcomes
Develop the environment to harness the opportunity for technology convergence in Ireland.
n Number of convergent technology products developed and commercialised.
n Ireland’s reputation as a destination for commercialisation of convergent technology is enhanced.
How Ireland is innovating for future healthcare and economic growth 19Key performance indicators / continued
ENTREPRENEURSHIP
Nurturing entrepreneurship
Develop policies and conditions where entrepreneurship can thrive.
n Positive policies and conditions to promote entrepreneurship and new start-ups.
n Number of impactful Irish Medtech mentor-mentee partnerships established.
n Increase in the number of start-ups.
n International best practice for start-ups identified and adopted.
MEMBER EXPERIENCE
Delivering real value to members
Provide high-quality services to member organisations that will impact positively on their business performance.
n Increase provision of industry specific, high-quality training for member organisations.
n Increased networking and sharing of best practice amongst member organisations.
n Member satisfaction with services Irish Medtech provides.
n Continued culture of business excellence.
n Growth in members’ business.
20 Irish Medtech Association Statement of Strategy 2016-2020We are experiencing
the age of the
empowered patient.
New strategies that
truly resonate with
the marketplace
will be needed.
How Ireland is innovating for future healthcare and economic growth 21Mapping our
CREATED BY
world-class
medtech 109 110 114
113
The Irish Medtech Association is the Ibec
group that represents the medical
technology industry in Ireland.
sector
108 111
004 005 006 023 027
033 036 044 047 048 240 250 259 335
SLIGO
049 054 062 074 085 338 343 351 366
397 399
018 061 078
227 229 234 354
003 112
032
DUNDALK
026 034
015 043 055 056 077 089 222 223 228 230 231 233
069 070 087
CASTLEBAR 236 257 261 322
288 244 245 246 248 249 251
017 252 253 254 255 260 262
384
224 325
263 264 265 266 267 268
LONGFORD
063 242
072 088 225 273 362 269 274 275 276 277 278
279 280 281 282 283 284
071 256 258
286 289 290 291 292 293
ATHLONE
001 002 007 008 009 010 011 012 013 014
016 019 021 022 024 025 028 029 030 031
237 327
321
DUBLIN 294 295 296 297 299 300
082 096 235 342 395 287 301 302 303 304 305 306
035 037 038 039 040 042 045 046 050 051
GALWAY
243
064 238 336 396 307 308 309 310 311 312
052 053 057 058 059 060 065 066 067 068 363 373
232 247 270
073 020 387 353 313 314 316 317 318 320
337 075 076 079 080 081 083 084 086 090
271 315
323 324 326 328 329 330
091 092 093 094 097 098 099 100 101 102 041 095
331 332 333 334 339 340
103 104 105 106 107
150
196
155
200
180
205
186
ENNIS 144
160
341
350
344
355
345
356
346
357
347
358
349
359
241 298 348 390
153 226
SHANNON
360 361 364 365 367 368
126 127 130 133
116 117 134 137 140 141 369 370 372 374 376 377
138 139 187 188
145 152 154 156 157 162
198 220
LIMERICK 123 285
379
378 380
379 381
380 381 382 383
164 170 172 173 174 175 386
385 388
386 389
388 389 391 392
118
176 184 185 193 206 208 407 394
393 398
394 400
398 400 401 402
128 122
209 210 404
403 405
404 406
405 406 408 409
178 239
199 217 218
272 285 352
371
WATERFORD 115 121 132 136 142 168
135 169 183 203 215 216
119 181
166
202
CORK
197 204 195
Contract research,
development, design
and/or manufacturing West Region 16
17
18
Galway Tool And Mould Ltd
Harmac Medical Products
iNBLEX Plastics
Diagnostic 120 124 125 129 131 143 146 147 148 149 151 158
19 Irish Micro Mouldings Ltd
CONTRACT RESEARCH, DEVELOPMENT, 20 Itronik Interconnect Ltd
159 161 163 165 167 171 177 179 182 189 190 191 DESIGN AND/OR MANUFACTURING 21 Lake Region Medical
Health Software (International Research &
192 194 201 207 211 212 213 214 375 219 221 1 Advant Medical Development Centre)
2 Advant Moulding 22 M & M Qualtech Ltd
Hospital and/or 3 Alpha Precision
homecare products 23 MB Mediprint
4 Amcor Flexibles Sligo 24 Metal Improvement Company
PRODUCED IN ASSOCIATION WITH
5 Arrotek Medical 25 Outsource Technical Concepts Ltd
Ophthalmic 6 Avenue Mould Solutions Ltd 26 Prior PLM Medical
7 Cambus Medical 27 ProTek Medical Ltd
8 Caragh Precision 28 Proxy Biomedical Ltd
Orthopaedic 9 Clada Medical Devices 29 Riteway Precision Engineering Ltd
10 Contech Medical 30 Saotharlann Chonamara Teo
11 Creganna Medical 31 Synecco Ltd
Service 12 Custom Equipment Solutions Ltd 32 Vention Medical Ireland Ltd
13 Dawnlough Ltd 33 Verus Precision
14 DiaNia Technologies Ltd 34 VistaMed
Vascular 15 Fort Wayne Metals Ireland Ltd 35 Vornia Ltd
22 Irish Medtech Association Statement of Strategy 2016-2020DIAGNOSTIC
36 Abbott Ireland Diagnostic
Division
North Region 168 Relate Care
169 Rigney Dolphin Ltd
240
241
242
M & V Medical Devices Ltd
Mediplast
Mergon International
328
329
330
ENBIO Ltd
Euro-Cast (Ireland) Ltd
Fannin Healthcare
37 Alere International Ltd HOSPITAL AND/OR 243 MGS Mfg Group Ireland Ltd. 331 Fresenius Medical Care
38 Beckman Coulter Biomedical CONTRACT RESEARCH, HOMECARE PRODUCTS 244 Movement Industrial Design (Ireland) Ltd
39 Enterasense DEVELOPMENT, 170 Adhesives Research Ireland Ltd 245 neoSurgical Ltd 332 Gabriel Scientific Ltd
40 Fannin Ltd DESIGN AND/OR MANUFACTURING 171 AventaMed 246 Novaerus Ltd. 333 Glanta Ltd
41 Natus Manufacturing Ltd 172 Bioquell Global Logistics 247 Nypro Healthcare 334 Incereb Ltd
108 Moll Industries Ireland Ltd 248 Oceana Therapeutics Ltd 335 Innocoll Technologies Ltd
109 Phillips-Medisize Ireland 173 Class Medical
HEALTH SOFTWARE 174 Cook Medical 249 Opko Ireland R&D Limited 336 Integra Lifesciences Ireland Ltd
110 Zeus Industrial Products 250 PPD Development Ireland Ltd 338 KCI (an Acelity Co)
42 Emedia (Ireland) Ltd 175 Deviate Aspire
176 Fleming Medical Ltd 251 Pressco Ltd 339 Mallinckrodt Pharmaceuticals
43 Full Health Medical 252 Profector Life Sciences 340 McKesson Ireland
44 Socrates Healthcare Ltd DIAGNOSTIC 177 GE Healthcare Global
Manufacturing Site 1 253 Renishaw Electronics 341 Meditec Medical Ltd
45 SyncroPhi Systems Ltd 111 Abbott Diabetes Care 254 Specialty Coating Systems 342 Medtronic
46 VASGARD 178 Irema Ireland
Donegal 179 PMD Solutions 255 Tech Group Europe Ltd 343 Medtronic
180 Vitalograph (Ireland) Ltd 256 Technical Engineering Group 344 Miravex Ltd
HOSPITAL AND/OR HOSPITAL AND/OR Tool and Plastic Industries Siemens Healthcare Medical
HOMECARE PRODUCTS 181 Young Microbrush Ireland Ltd 257 345
HOMECARE PRODUCTS Company Ltd Solutions Limited
47 Abbott Ireland 112 Abbott Ireland Nutrition OPHTHALMIC 258 Trend Technologies Mullingar Ltd 346 Smartsplint
48 Abbott Nutrition Ltd Division 259 Utah Medical Products Ltd 347 Trulife Ltd
49 AbbVie Medical Device 182 Alcon Laboratories Ireland Ltd 348 VascoCare Medical Ltd
50 Aerogen Ltd 183 Bausch + Lomb Ireland DIAGNOSTIC 349 Vasorum Ltd
SERVICE 184 Essilor
51 AeroSurgical Ltd 260 Aalto Bio Reagents Ltd
52 AOTI 113 Bemis Healthcare Packaging 185 Johnson & Johnson Vision Care OPHTHALMIC
114 Randox Teoranta 186 Organic Lens Manufacturing 261 Abbott Ireland Diagnostic
53 Arc Devices Ltd Division 350 Abbott Medical Optics
54 B.Braun Hospicare Ltd 262 Biosensia Group Limited 351 Athlone Optical
ORTHOPAEDIC
South Region
55 Baxter Healthcare SA 263 DiaSorin Diagnostics Ireland Ltd 352 Carl Zeiss Vision Ireland Ltd
56 Baxter Healthcare SA 187 Archway Orthotics Limited 264 EKF Diagnostics 353 Rupp + Hubrach Optik Gmbh
57 Bio Medical Research Ltd 188 Celgen Tek Ltd. 265 Enzolve Technologies Ltd
58 Crospon Ltd 189 DePuy Synthes Ireland 266 Kjaya Medical Ireland Ltd ORTHOPAEDIC
59 Envaste Ltd CONTRACT RESEARCH, 190 PPL Biomechanics 267 Medtronic
60 Gate Dental Services Ltd 191 SOTA Prosthetics and 354 Allard UK
DEVELOPMENT, 268 Quest Diagnostics 355 Mainstay Medical Ltd
61 Hollister ULC DESIGN AND/OR MANUFACTURING Orthotics Ltd 269 Siemens Healthcare
62 Hospira 192 Stryker 356 SurgaColl Technologies Ltd
Diagnostics Manufacturing 357 X-Bolt Orthopaedics
63 Idoman Teoranta 115 APS Materials 193 Stryker 270 Tcoag
64 Lifewave Europe 116 BD Gencell 194 Stryker 271 Trinity Biotech Plc
65 Medtronic 117 Croom Precision Medical Ltd 195 Tecomet Ireland SERVICE
272 Waters Technologies Ireland Ltd
66 Mylan Teoranta 118 Designwise Automation Ltd 196 TOG Orthotics 273 Welch Allyn Ltd 358 3M Ireland
67 Pointec Medical 119 Europfins Medical Device 197 Tornier Orthopedics Ireland 359 Abbott Ireland
68 Vysera Biomedical Ltd Testing Ltd (Wright Medical Group) HEALTH SOFTWARE 360 Allergan Pharmaceuticals Ireland
337 Janisys Ltd 120 Excelsy Technologies Ldt 198 Zimmer Biomet 361 Anecto Ltd
121 FastForm Research Ltd 274 Ace Health Innovations Ltd 362 AQF Ltd
OPHTHALMIC 122 Filtertek – An ITW Medical SERVICE 275 Air Liquide Healthcare 363 Ash Technologies Ltd
Company Ireland Ltd 364 Autocal (Ireland) Ltd
69 Abbott Medical Optics 123 Firebird Medical Ltd 199 Acorn Regulatory 276 Beats Medical
70 Allergan 200 AiP Thermoform Packaging 365 Baxter Shared Services &
124 Flextronics Ireland 277 SilverCloud Competencies Ltd
71 Transitions Optical Ltd 125 Flextronics Ireland 201 Crest Solutions 278 Captec Ltd
72 Moss Vision 202 DGP Group 366 Bioclin Research Laboratories
126 Gentian Services Ltd 279 Cerner Ireland Ltd 367 Catalent Pharma Solutions
127 Hi-Life Tools 203 EC Labels Ltd. 280 Clindox Ltd.
ORTHOPAEDIC 204 Eurofoil Teo 368 Claymon Biomimnis
128 Listal Ltd 281 Clinical Trial EndPoint (CTEP) Ltd 369 Colorman (Ireland) Ltd
73 APOS Ltd 129 Merck Millipore Ireland Ltd 205 Fahy Analytical Ltd 282 Clintech Health Care Ltd
206 Firecrest Clinical Ltd 370 Connexicon Medical Ltd
74 Firefly Orthoses Ltd 130 Molex Ireland 283 dabl 371 Consort Case Company
75 Zimmer Biomet 131 MTD Precision Engineering Ltd 207 Imstec Gmbh 284 DMF Systems Ltd
208 Kneat Solutions Ltd (Ireland) Ltd
132 Nypro Healthcare Waterford 285 Emergency Response Ltd 372 DQS Ireland Limited
SERVICE 133 Phardiag 209 M & Q Packaging 286 Global Diagnostics Ltd
210 Olympus Biotech Ireland 373 DSV Solutions
134 RR Donnelley 287 HealthComms 374 Essentra Packaging Ireland Ltd
76 Anecto Ltd 211 Pharma-Bio Serv 288 Heart Rhythm International
77 Cashin Print 135 Sanmina 376 Fountain Healthcare
136 Schivo Precision Ltd 212 Qualtech Pharma Ltd 289 Helix Health Ltd
78 Charles River Laboratories 213 QUMAS Ltd 377 GE Healthcare Sales And
137 Shannon MicroCoil Ltd 290 IMS MAXIMS Service Support
Ireland Limited 214 Seabrook Technology Group Ltd 291 IncaClinic
79 CLS Medpharma 138 Smart Electronics Ltd 378 ICON Research
139 Smithstown Light 215 Sightrisk Ltd 292 Incaplex Ltd
80 Embricon Ltd 216 Tegan Innovations Ltd 379 IMEC Technologies
Engineering Ltd 293 InsulCheck 380 Integra Lifesciences
81 Hospicode Ltd 375 EtQ Ltd 294 INTEL – Digital Health Group 381 Java Clinical Research Ltd
82 KPW Print 140 Takumi Precision
141 Teleflex Medical 295 LZ Lifesciences 382 KCI Medical
83 Lip (Diagnostic Services) Ltd VASCULAR 296 MANITeX
84 NeliPak Healthcare 142 West Pharma 383 Komax Systems LCF SA
217 Abbott Ireland Vascular 297 Manitex Ltd 384 MDI Medical
Packaging 298 Netcare Wellness
85 Orreco Ltd DIAGNOSTIC 218 Boston Scientific Clonmel 385 Mead West Vaco
219 Boston Scientific Cork Ltd 299 Neuromod Devices Ltd 386 Medtronic
86 Specialised Sterile 143 Audit Diagnostics 300 Ocuco Ltd
Environments (SSE) 144 Beckman Coulter Ireland Inc 220 DMC Medical Ltd 387 ModusLink Kildare
221 Stryker 301 Tickerfit 388 Mylan Dublin Respiratory
87 Synergy Health Ireland Ltd 145 Crescent Diagnostics LTD 302 Oneview Healthcare
88 System Label 146 Metabolomic Diagnostics 389 Omega Teknika Chefaro Ireland
303 OpenApp 390 OptiCal Sciences
East Region
89 Volex Europe 147 Neonatal Diagnostics 304 PMI Software Ltd
148 Radisens Diagnostics 391 Quintiles Ireland Ltd
305 Presidion 392 Sealpack Labelling Systems
VASCULAR 149 Raman Diagnostics 306 ResMed
150 Roche Ireland Ltd 393 Seroba Life Sciences
90 4Tech Cardio Ireland 307 S3 Group Ltd 394 Specialised Sterile
91 Apica Cardiovascular 151 SensL Technologies Ltd CONTRACT RESEARCH, 308 SensorMind Ireland
152 Serosep Ltd Environments (SSE)
92 ArraVasc Ltd DEVELOPMENT, 309 Shimmer 395 SteriPack
93 Boston Scientific Galway 153 Technopath Manufacturing DESIGN AND/OR MANUFACTURING 310 Sláinte Healthcare 396 Synergy Health Ireland Ltd
94 Capsos Medical 222 Adama Innovations 311 Swiftqueue Technologies Ltd 397 Teleflex Medical Europe Ltd
95 CareFusion Manufacturing HEALTH SOFTWARE 312 Tele Health Services Ltd
223 Allied Automation Ltd. 398 Venn Life Sciences Ltd
96 Creagh Medical Ltd 154 Advanced Manufacturing 224 AmRay Medical 313 Two-Ten Health Ltd 399 Zenith Adhesive Components
97 Delcath Systems Inc Control Systems (AMCS) 225 AQF 314 Valentia Technologies Ltd 400 Fannin Ltd
98 Embo Medical 155 BodyTab Ltd 226 Automatic Plastics Ltd 401 Homecare Medical Supplies
99 Goodman Medical Ireland 156 Clinical Support Information 227 Bellurgan Precision HOSPITAL AND/OR 402 i360 Medical
100 Marvao Medical Devices Systems Ltd Engineering Ltd HOMECARE PRODUCTS 403 Multivac Ireland Ltd
101 Medtronic 157 CliniSynergy Ltd 228 Bioplastech Ltd 315 Advanced Surgical Concepts 404 SA Partners Consultancy
102 Merit Medical Ireland Ltd 158 Crest Solutions Ltd 229 Blueacre Technology Ltd 316 Allogen Biotech 405 SysCom Project
103 Neuravi 159 DB MATTERS 230 BlueBridge Technologies 317 AltaScience Management
104 Novate Medical Limited 160 Doctot 231 Curtiss Wright 318 Arann Healthcare 406 VWR International Ireland
105 Vascular Solutions Zerusa Ltd 161 Epic Solutions Ltd 232 Design Partners 319 ArcRoyal Ltd
106 Veryan Medical Ltd 162 i360 Hygiene 233 Dolmen Design 320 Ardoo Caresafe Ltd VASCULAR
107 Vivasure Medical Ltd 163 Independent Data 234 Endura Coatings Ltd 321 Astora Women’s Health
Management Ltd 407 ClearStream Technologies
235 Europharma Concepts 322 B Braun Longford Ltd (CR Bard)
164 Kneat Solutions Ltd 236 Finesse Medical Ltd 323 B Braun Medical Ltd
165 Lincor Solutions Ltd 408 NeuroTronik Ltd
237 Innovative Polymer 324 BD Penel Ltd 409 PQ Bypass
166 Portable Medical Compounds IPC 325 BD Penel Ltd
Technology Ltd 238 Kelpac Medical Ltd 326 Centric Health
167 Realtime Technologies Ltd 239 Lake Region Medical 327 Critical Healthcare Ltd
While the coordinators have made every effort to ensure that the information in this map is accurate, we do apologise for any inconsistencies. Stakeholders who wish to amend map, please contact
Irish Medtech on 01 6051529 or info@medtechireland.com. It is anticipated that updates will be supported on an ongoing basis and completely at the discretion of Irish Medtech.
Date of Publication: February 2016. E&OE.
How Ireland is innovating for future healthcare and economic growth 23About Ibec
Ibec is the national voice of business in Ireland.
The organisation and its sector associations, work
with government and policy makers nationally
and internationally, to shape business conditions
and drive economic growth. Ibec’s strength lies
in its diversity. We offer our members a range of
professional services and training on human resource
management, occupational health and safety,
employee relations and employment law.
www.ibec.ie
Join the conversation by tweeting @ibec_irl
24 Irish Medtech Association Statement of Strategy 2016-2020About the Irish
Medtech Association
The Irish Medtech Association (formerly the Irish Medical
Devices Association) is the Ibec group that represents
the medtech industry in Ireland. Irish Medtech’s broad
focus is to promote and support an environment that
encourages the sustainable development and profitable
growth of our multinational and small to medium size
medical device and diagnostic companies.
By forging close working relationships with ministers, government agencies, policy makers and other
relevant governing bodies Irish Medtech helps members navigate the challenges facing both multinational
and indigenous medical device and diagnostic companies. On behalf of our members, we work to bring
together clinicians, industry leaders, academia, government and health stakeholders to foster an
environment of growth, innovation and convergence in developing the medical devices and diagnostic
products and solutions of tomorrow.
www.irishmedtechassoc.ie
Join the conversation at @IrishMedtech
How Ireland is innovating for future healthcare and economic growth 25Board of the Irish Medtech
James Winters Conor Russell Barry Comerford
Chair Vice-Chair Barry is the CEO and co-founder of
James Winters is the Vice President Conor Russell is currently Vice Cambus Medical.
of Manufacturing, Global joint President for Boston Scientific
Career highlights include;
Reconstruction and is responsible Clonmel and has over 18 years
for the DePuySynthes manufacturing of experience with Boston n Graduating as “Best Fitter
facilities achieving world-class Scientific in the development Armourer” from the Irish
performance in EHS&S and quality and manufacturing of Class 3 Army’s Apprentice School,
compliance, service, cost and asset implantable medical devices. Naas, Co. Kildare.
efficiency across the joint business
n Starting a Packaging
manufacturing network. James also Prior to his current role, he has
Machine business with
chairs the DePuy Ireland Joint Global held numerous Engineering and
Sean, his late father.
Supply Chain board. Operational roles within Boston
Scientific including six years in the n Gaining a MBA from
Prior to this, James was the Plant United States in their California NUI, Galway.
Manager for the DePuySynthes Ireland and Minnesota facilities.
n Successfully guiding Cambus
Manufacturing Operation. In this role,
Medical into a joint venture
James was responsible for leading He is originally from New Ross
partnership with Freudenberg
and managing the Cork Manufacturing in Co Wexford and has a degree
Medical in 2012.
site as well as continuing to accelerate in Mechanical Engineering and a
the transformation of operations Masters in Industrial Engineering n Becoming a Board Member
to a fully integrated LEAN supply from University College Dublin. of the Irish Medtech Association.
chain. As a result of this effort, the
n Chairman of the Irish
DePuySynthes Ireland site was
Medtech Apprenticeship
awarded the Shingo Prize in 2014.
Steering Committee
James joined the DePuy Ireland
Barry is a highly motivated
Global Supply Chain team in August
entrepreneur and professional
2005 as the Sales and Operations
manager, with extensive experience in
Planning Manager, transitioning
the medical device industry. He has a
to a combined Operations /
proven track record in building teams
Materials Manager role within the
and networks to manage complex
manufacturing facility in August 2006.
systems at strategic, administrative
In 2008, he transitioned into a multi-
and technical levels. Through the
faceted role of Engineering, Technical
course of his career, he has gained
Services and Materials Manager prior
a wide range of knowledge in global
to taking overall plant management
business strategy, negotiations,
responsibility in January 2010.
engineering, sales, operations, quality
systems and leadership; from start-up
Prior to DePuy, James worked with
through to high growth environments.
Sanmina–SCI in varying roles.
James holds a BTech in Electronic
Manufacturing from the University
of Limerick and an MBA from
University College Cork.
26 Irish Medtech Association Statement of Strategy 2016-2020Association
Bill Doherty Ciaran Corcoran Conor Hanley
Bill Doherty is Managing Director of Ciaran Corcoran is the Site Director Conor Hanley is President and
Cook Medical’s Irish operations and with Abbott Diagnostic Longford CEO of Foundry Innovation and
Executive Vice President of Cook (Shingo Prize Recipients in 2016). He Research 1 Ltd (FIRE1).
Group Europe with responsibility for has a PhD in Organic Chemistry and
Cook Medical’s EMEA business. a degree in Biology and Chemistry, Prior to joining FIRE1, Hanley held
from Maynooth University, Ireland. senior management positions
Bill is a board member of both the Irish with ResMed, including leading
Medtech Association and Eucomed He has over 16 years of experience the Company’s Chronic Disease
and has over twenty years experience in various companies including Management Solutions division, its
in the medtech industry. Bill is also Mallinckrodt, Abbvie Pharma, Abbott Cardiology business, and its Ventures
a member of the advisory board of Diagnostics and Abbott Biologics in and Initiatives business units.
the Materials and Surface Science the areas of start-up, research and
Institute (MSSI) at UL (University of development and operations. Prior to ResMed, he was CEO and
Limerick) and the advisory board of co-founder of BiancaMed, which
LIT (Limerick Institute of Technology). Ciaran moved from Abbott Pharma commercialised a novel method to
to Abbott Diagnostics Longford provide connected health solutions,
Bill is a member of the Expert Group in 2009 and was Operations and was acquired by ResMed
on Future Skills Needs advising the manager there for two years, in this in 2011.
Irish Government on current and time the Operational Excellence
future skills needs and on other labour Journey kicked off. After a four year Hanley received a PhD in Chemical
market issues that impact on Ireland’s assignment as Site Director in Abbott Engineering from the University of
enterprise and employment growth. Diagnostics Biologics facility in the Pennsylvania, an MBA from INSEAD,
Bill holds a B.Eng. (Electrical) from UK, Ciaran returned in March 2015 to and a First Class Honours B.E. from
University College Dublin and an MBA Longford as Site Director. He strongly University College Dublin.
from Trinity College Dublin. supported the sites journey and
lead into Shingo Assessment with a
successful outcome in receiving the
Shingo Prize.
How Ireland is innovating for future healthcare and economic growth 27Board of the Irish Medtech Association continued
Damain Finn David Tallon Donal Balfe
Damain Finn was appointed general David Tallon is currently Vice Donal Balfe was born and educated
manager of Bausch & Lomb Waterford President of Research and in Dublin, Ireland. He graduated
in 2012, having previously served as Development for Stryker’s Neuro, in Business from Dublin City
financial controller to the contact Spine, ENT and Navigation business University in 1992.
lens manufacturing and eye units with responsibility for R&D sites
healthcare business. in the US, Germany, Ireland and Prior to joining with Medtronic, Balfe
Japan. He leads the development was employed as Operations Director
Now part of the Valeant group, of a diverse range of integrated at Bayer Diagnostics. He joined
Bausch & Lomb is a leading global products and technology solutions Medtronic in 2000 and served as
developer, manufacturer and marketer which are used in Neuro, Spine Manufacturing Director of plants
of eye health products, dedicated to and ENT surgery. in the UK and Ireland.
perfecting vision and enhancing life
for consumers around the world. The During his 25 year career he has held Currently Donal is Vice President
product portfolio is one of the most various engineering and leadership of Operations with responsibility
comprehensive in the ophthalmic positions in R&D and Engineering for Manufacturing plants in Europe
industry, with leading market positions within the medical device, automotive and Asia along with operations
in several leading product categories. and mining industries. Most recently responsibility for Medtronic’s Renal
Products are available in more than as Vice President of Technology Care Solutions business.
100 countries, and the Bausch & and Procedural Innovation in Stryker
Lomb name is one of the best-known Instruments division, he led the In 2009 Balfe was appointed
and most respected eye health brands establishment of a state-of-the-art to the Board of Directors of the
in the world. The Waterford plant Surgical Innovation and R&D Centre Irish Medtech Association and
is the largest manufacturing facility in Cork which is based on human- in 2015 served as Chairman
within the group employing 1,100 centered design principles and which of the Association.
people. In addition to contact lenses, includes a fully integrated operating
the multi-disciplinary campus also theatre for surgery simulation.
manufactures a pharmaceutical back
of the eye implant. He has championed the transition
from a product-focused R&D
Damain is a Fellow of the Chartered organisation to a clinical and
Institute of Management Accountants procedural innovation R&D culture.
and holds a diploma in Management He has a passion for technology
Information Systems from the Irish strategy and innovation roadmapping,
Management Institute. for building customer centric R&D
teams, and for driving collaboration
globally with customers across
R&D locations and with external
research partners.
28 Irish Medtech Association Statement of Strategy 2016-2020Garret Coady Jackie Murphy John O'Brien
Co-founder of BBT. Responsible for Jackie is the Site Head and General John O’Brien is S3 Group’s Chief
day-to-day management of all aspects Manager of Alcon Ireland, a Novartis Executive Officer and a member of
of the business. 20 years industrial division. She joined the company as a the company’s Board of Directors.
experience with a background in R&D, Manufacturing Engineer when it was Under John’s leadership, the S3
engineering, product development, Summit Technology, a manufacturer Group team has created multiple
structured Innovation, management of refractive lasers for corrective eye businesses in the Digital Health,
and business development. surgery, and progressed to Head Semiconductor, Digital TV and
of Manufacturing. Communications sectors.
Experience in assembling and John has extensive experience in
managing interdisciplinary teams After Alcon acquired Summit in 2000, business creation and strategy,
from physiology, physical sciences, the Cork plant was repurposed to an business development, and
consultant physicians, medical device Intraocular lens manufacturing site corporate finance including
marketing and specialist medical with Jackie as the General Manager. fund raising, acquisitions and
component vendors. In 2006, the Cork plant began successful business exits.
manufacturing Alcon’s AcrySof®
Successfully working with the teams in intraocular lenses (IOLs), which John is currently an active member of
assessing the performance of in-vivo replace the eye’s natural lens in the Irish Software CEO Forum and is
biomedical sensors and managing cataract surgery. In 2009, Jackie took a member of both the Executive
the end-to-end product development a three year assignment as General Council of the Irish Software
process up to device launch. Product Manager of Alcon’s US Intraocular Association and a board member
Development and Management lens/delivery device site in Huntington of the Irish Medtech Association.
Association, PDMA, obtained New West Virginia. She returned to Ireland
Product Development Professional in 2013 and has continued to grow He is an engineering graduate from
NPDP since 2008. the Cork site where it employs over the University of Limerick, having
450 people today. graduated in 1984 with a Bachelor’s
Degree in Engineering (B.Eng.).
Jackie holds a degree in Engineering He earned his MBA (1992) from
(Production) from the University of the Smurfit Business School at
Limerick as well as a Master’s in University College Dublin. John has
Business Administration. also completed the Enterprise Ireland
Leadership for Growth program at
Stanford University.
How Ireland is innovating for future healthcare and economic growth 29Board of the Irish Medtech Association continued
John Power Michael O'Reilly Padhraic McGinn
John has been a founder of several Michael O’Reilly is Managing Director Padhraic is currently the Senior
technology start-ups and has held of Phillips-Medisize Ireland. Michael Operations Director for Nypro
executive level positions in R&D, joined Medisize Ireland in 2006 Healthcare with accountability for
Operations, Sales and General as General Manager. From 2008 manufacturing sites across Europe
Management in both SME’s and to 2011 he served as Director of supporting pharmaceutical delivery
MNC’s. The European Business Primary Pharmaceutical Packaging systems, diagnostics and medical
Awards declared John their European at Medisize Corporation with devices business sectors.
Entrepreneur of the Year 2015/16. responsibility for its operations in
Ireland and Switzerland, during Prior to this role he was General
Aerogen has become recognised this period Michael served on the Manager of Nypro Healthcare Ireland
as the global leader in aerosol drug management team of the corporation. site with oversight for manufacturing
delivery in the Acute Care setting and supply of complex respiratory and
recording over 30% CAGR 2008- Phillips-Medisize Ireland is engaged in auto injector medical devices.
15. Its products have been pivotal the manufacture of complex medical
in treating more than 4m critically ill devices and primary pharmaceutical Padhraic also worked for Wyeth for
patients from 70 countries around packaging employing 293 at its over 10 years in various executive
the world. Last year Aerogen receive Letterkenny facility. roles including Engineering Director
the prestigious Zenith Award from the and Operations Director (CNS
American Association of Respiratory Michael served as President of Ibec’s and Immunosuppressant global
Care and in prior years has been North-West region from 2013 to 2015 product supply). He previously
awarded both the Irish Exporter of and was appointed to the Board held positions with Organon as
The Year and the Irish Medical Device of the Irish Medtech Association in Engineering Manager and Allergan
Technology Company of The Year. December 2015 Pharmaceuticals as project lead.
John holds an MBA from Oxford Michael holds a Master in Business He holds a BSc Eng. – Trinity College,
Brookes University and as a Chartered Studies from Letterkenny Institute University of Dublin, Dip Eng. – Dublin
Engineer he is accredited with many of Technology. Institute of Technology and MBA –
commercialised International patents. University of Limerick. He is a Fellow
As an Adjunct Lecturer at National of Engineers Ireland, Eur Eng and has
University of Ireland, Galway he served as Chair of the Irish Medtech
guest lectures on his core business Association Op Ex taskforce
interests of innovation strategies and in 2014.
technology entrepreneurship. He is
a member of the Board of the Irish
Medtech Association.
30 Irish Medtech Association Statement of Strategy 2016-2020Paula McGrane Tony Kennedy
Paula McGrane is a Senior Director of Teleflex is a global provider of medical
Business Planning and Administration, technologies designed to improve
Northern Europe, CEE, France and the health and quality of people’s
Switzerland for KCI/Acelity. Paula lives. We apply purpose driven
is a Chartered Accountant and innovation – a relentless pursuit of
has worked within the KCI/Acelity identifying unmet clinical needs –
business since 2005. to benefit patients and healthcare
providers. Our portfolio is diverse,
In her role she is responsible for the with solutions in the fields of vascular
following: Business partner with two and interventional access, surgical,
Regional VPs in areas including Go to anaesthesia, cardiac care, urology,
market strategy (direct V distributor emergency medicine and respiratory
business model), integration of care. Teleflex employees worldwide
the three business units into a are united in the understanding
combined team and strategic that what we do every day
pricing management. makes a difference.
She is also responsible for identifying Tony joined Teleflex in July 2007 and
and monitoring significant business is responsible for Global Operations
trends and variances to plan in which comprises of procurement,
revenue, expenses, headcount, manufacturing, logistics and
capital, balance sheet and cash flow distribution, as well as all
items and alert senior leadership to supporting functions.
issues and drive corrective action.
Prior to joining Teleflex, Tony spent
She leads the annual budget and more than 20 years in different senior
quarterly forecasting processes within management roles in operations,
the region by coordinating country supply chain and quality in Saint
management involvement with Gobain, Biomedical Research
country analysts in Budapest SSC. Limited, Marconi Plc, Fore Systems
She manages cross-functionally to Inc., American Power Conversion
ensure alignment across organization Corporation, General Electric,
of key success factors and initiatives Philips, Western Digital and Wang
drive toward expected results. And Laboratories. Tony earned a Master’s
develops and maintain business and degree in Business Administration
financial models to support internal from University College Galway and a
decision making processes and Bachelor’s degree in Engineering from
external stakeholder negotiations. the University of Limerick. Tony is also
a Qualified Executive Coach.
How Ireland is innovating for future healthcare and economic growth 31Ibec
Danny McCoy Sinead Keogh
CEO, Ibec Director, Irish Medtech
Danny McCoy is CEO at Ibec, the Sinead Keogh took up the position
group that represents Irish business of Director of the Irish Medtech
domestically and internationally. Since Association – formerly IMDA – the
becoming CEO in 2009, he has led Ibec sector group in July 2013,
a substantial transformation of Ibec having previously worked at the
increasing turnover to €26 million, Association since 2005. With over
leading a professional services staff 200 members located throughout
of 180 in seven locations and 40+ the island of Ireland, Irish Medtech's
sub-brands. broad focus is to promote and support
an environment that encourages
Prior to joining Ibec he was a senior the sustainable development and
economist at both the Economic and profitable growth of our multinational
Social Research Institute (ESRI) and and indigenous medical device and
the Central Bank of Ireland. He has diagnostic companies.
held lecturing posts at Dublin City
University, University College London, In her capacity as Director, Sinead
University of Oxford and Trinity currently sits on a number of
College Dublin and has been a visiting national and international boards
lecturer at the IMD Business School including HIQA’s HTA Advisory
in Switzerland and Harvard University Board, Regulatory Science Ireland
in the US. He has been a consultant and the Board of BioInnovate.
for the European Commission In Europe, Sinead is a member
and the OECD. of the EU National Associations
Committees at both Eucomed and
He is a member of the Irish National EDMA. In February 2015, Sinead
Competitiveness Council, the National was appointed Director of a newly
Economic and Social Council and established Medtech and Engineering
the Export Trade Council. His sits on group at Ibec, which houses four
BusinessEurope Executive Committee trade associations.
and the OECD-BIAC working group
on Corporate Taxation. She holds a PhD in nanotechnology
from the Dublin Institute of Technology
Danny correctly identified the and professional qualifications in
turnaround in the Irish economy prior business and marketing. Sinead has
to the EU Troika programme and led previously worked for 3Com and
media campaigns around driving the lectured part-time at DIT.
recovery. He has made significant
speeches to the United Nations ILO
plenary in Geneva; to the European
Business Summit in Brussels; spoken
at conferences in the New York and
London Stock Exchanges, at the IMF
in Washington DC, the World Trade
Organisation in Geneva.
32 Irish Medtech Association Statement of Strategy 2016-2020You can also read
